Cluster Headache and Hypoxia: Breathing New Life into an Old Theory, with Novel Implications

Overview

Journal Neurol Int

Publisher MDPI

Specialty Neurology

Date 2024 Dec 27

PMID 39728749

Authors

Jonathan M Borkum

Affiliations

Soon will be listed here.

Abstract

Cluster headache is a severe, poorly understood disorder for which there are as yet virtually no rationally derived treatments. Here, Lee Kudrow's 1983 theory, that cluster headache is an overly zealous response to hypoxia, is updated according to current understandings of hypoxia detection, signaling, and sensitization. It is shown that the distinctive clinical characteristics of cluster headache (circadian timing of attacks and circannual patterning of bouts, autonomic symptoms, and agitation), risk factors (cigarette smoking; male gender), triggers (alcohol; nitroglycerin), genetic findings (GWAS studies), anatomical substrate (paraventricular nucleus of the hypothalamus, solitary tract nucleus/NTS, and trigeminal nucleus caudalis), neurochemical features (elevated levels of galectin-3, nitric oxide, tyramine, and tryptamine), and responsiveness to treatments (verapamil, lithium, melatonin, prednisone, oxygen, and histamine desensitization) can all be understood in terms of hypoxic signaling. Novel treatment directions are hypothesized, including repurposing pharmacological antagonists of hypoxic signaling molecules (HIF-2; P2X3) for cluster headache, breath training, physical exercise, high-dose thiamine, carnosine, and the flavonoid kaempferol. The limits of current knowledge are described, and a program of basic and translational research is proposed.

References

Ishiguro T, Iwase M, Kanamaru M, Izumizaki M, Ohshima Y, Homma I . Impaired ventilation and metabolism response to hypoxia in histamine H1 receptor-knockout mice. Respir Physiol Neurobiol. 2006; 154(3):331-41. DOI: 10.1016/j.resp.2006.01.017. View

DAmico D, Ferraris A, Leone M, Catania A, Carlin A, Grazzi L . Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway?. Cephalalgia. 2002; 22(1):33-6. DOI: 10.1046/j.1468-2982.2002.00304.x. View

Sun L, Luo C, Long J, Wei D, Liu J . Acrolein is a mitochondrial toxin: effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Mitochondrion. 2006; 6(3):136-42. DOI: 10.1016/j.mito.2006.04.003. View

Ji Y, Park J, Heo H, Park J, Park S . The neuroprotective effect of carnosine (β-alanyl-L-histidine) on retinal ganglion cell following ischemia-reperfusion injury. Curr Eye Res. 2013; 39(6):634-41. DOI: 10.3109/02713683.2013.855235. View

Jensen R, Lyngberg A, Jensen R . Burden of cluster headache. Cephalalgia. 2007; 27(6):535-41. DOI: 10.1111/j.1468-2982.2007.01330.x. View

Goadsby P, Dodick D, Leone M, Bardos J, Oakes T, Millen B . Trial of Galcanezumab in Prevention of Episodic Cluster Headache. N Engl J Med. 2019; 381(2):132-141. DOI: 10.1056/NEJMoa1813440. View

Silva T, Takakura A, Moreira T . Acute hypoxia activates hypothalamic paraventricular nucleus-projecting catecholaminergic neurons in the C1 region. Exp Neurol. 2016; 285(Pt A):1-11. DOI: 10.1016/j.expneurol.2016.08.016. View

. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38(1):1-211. DOI: 10.1177/0333102417738202. View

Bharadwaj L, Davies G, Xavier I, Ovsenek N . l-carnosine and verapamil inhibit hypoxia-induced expression of hypoxia inducible factor (HIF-1 alpha) in H9c2 cardiomyoblasts. Pharmacol Res. 2002; 45(3):175-81. DOI: 10.1006/phrs.2001.0911. View

10.

Vollesen A, Snoer A, Chaudhry B, Petersen A, Hagedorn A, Hoffmann J . The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache. Cephalalgia. 2020; 40(13):1474-1488. DOI: 10.1177/0333102420940689. View

11.

Hannerz J, Jogestrand T . Provocation of unilateral pain in cluster headache patients by breathing CO2. Headache. 1995; 35(1):38-43. DOI: 10.1111/j.1526-4610.1995.hed3501038.x. View

12.

Pistolesi A, Buonvicino D, Muzzi M, Urru M, Chiarugi A . Effects of cluster headache preventatives on mouse hypothalamic transcriptional homeostasis. Cephalalgia. 2022; 42(8):798-803. DOI: 10.1177/03331024221075613. View

13.

Silvestro M, Tessitore A, Orologio I, Battista G, Siciliano M, Tedeschi G . Cluster headache pathophysiology: What we have learned from advanced neuroimaging. Headache. 2022; 62(4):436-452. PMC: 9314615. DOI: 10.1111/head.14279. View

14.

Mifflin S, Cunningham J, Toney G . Neurogenic mechanisms underlying the rapid onset of sympathetic responses to intermittent hypoxia. J Appl Physiol (1985). 2015; 119(12):1441-8. PMC: 4683347. DOI: 10.1152/japplphysiol.00198.2015. View

15.

Wang X, Wu D, Yang L, Gan L, Cederbaum A . Cytochrome P450 2E1 potentiates ethanol induction of hypoxia and HIF-1α in vivo. Free Radic Biol Med. 2013; 63:175-86. PMC: 3729858. DOI: 10.1016/j.freeradbiomed.2013.05.009. View

16.

Akerman S, Holland P, Lasalandra M, Goadsby P . Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents. Headache. 2009; 49(8):1131-43. DOI: 10.1111/j.1526-4610.2009.01501.x. View

17.

Leone M, Lucini V, DAmico D, Moschiano F, Maltempo C, Fraschini F . Twenty-four-hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia. 1995; 15(3):224-9. DOI: 10.1046/j.1468-2982.1995.015003224.x. View

18.

HORTON B . Histaminic cephalgia. J Lancet. 1952; 72(2):92-8. View

19.

Mody P, Rukhadze I, Kubin L . Rats subjected to chronic-intermittent hypoxia have increased density of noradrenergic terminals in the trigeminal sensory and motor nuclei. Neurosci Lett. 2011; 505(2):176-9. PMC: 3220619. DOI: 10.1016/j.neulet.2011.10.015. View

20.

Cheng X, Prange-Barczynska M, Fielding J, Zhang M, Burrell A, Lima J . Marked and rapid effects of pharmacological HIF-2α antagonism on hypoxic ventilatory control. J Clin Invest. 2020; 130(5):2237-2251. PMC: 7190921. DOI: 10.1172/JCI133194. View